XML 71 R43.htm IDEA: XBRL DOCUMENT
v3.26.1

Merger and Related Transactions (Details) $ in Thousands |  | 12 Months Ended
--- | --- | ---
Mar. 21, 2024 USD ($) member shares | Dec. 31, 2025 USD ($) | Dec. 31, 2024 USD ($)
Reverse Recapitalization [Line Items] |  |  |
Number of board of directors, former stockholders | member | 5 |  |
Number of board of directors, combined company | member | 7 |  |
Issuance of common stock from private placement, net (in shares) | shares | 8,670,653 |  |
Recapitalization exchange ratio | 0.2022 |  |
Sale of stock, number of shares issued (in shares) | shares | 15,409,102 |  |
Sale of stock, consideration received | $ 53,500 |  |
Sale of stock, percentage of ownership following transaction | 56.00% |  |
Cash and cash equivalents acquired | $ 112,600 |  |
Assets acquired | 1,500 |  |
Payables and accruals acquired | 3,200 |  |
Merger transaction costs | $ 5,200 |  | $ 5,070
Acceleration of stock awards, expense |  | $ 300 |
Graphite Bio, Inc. Stockholders |  |  |
Reverse Recapitalization [Line Items] |  |  |
Sale of stock, percentage of ownership following transaction | 31.00% |  |
PIPE Investors |  |  |
Reverse Recapitalization [Line Items] |  |  |
Sale of stock, percentage of ownership following transaction | 13.00% |  |

X
- Definition Adjustments to Additional Paid in Capital, Recapitalization, Transaction Costs + References No definition available. + Details
Name: | lenz_AdjustmentsToAdditionalPaidInCapitalRecapitalizationTransactionCosts
Namespace Prefix: | lenz_
Data Type: | xbrli:monetaryItemType
Balance Type: | debit
Period Type: | duration

X
- Definition Assets Acquired Through Reverse Recapitalization + References No definition available. + Details
Name: | lenz_AssetsAcquiredThroughReverseRecapitalization
Namespace Prefix: | lenz_
Data Type: | xbrli:monetaryItemType
Balance Type: | debit
Period Type: | duration

X
- Definition Cash And Cash Equivalents Acquired Through Reverse Recapitalization + References No definition available. + Details
Name: | lenz_CashAndCashEquivalentsAcquiredThroughReverseRecapitalization
Namespace Prefix: | lenz_
Data Type: | xbrli:monetaryItemType
Balance Type: | debit
Period Type: | duration

X
- Definition Number Of Board Of Director Members, Former Stockholder + References No definition available. + Details
Name: | lenz_NumberOfBoardOfDirectorMembersFormerStockholder
Namespace Prefix: | lenz_
Data Type: | xbrli:integerItemType
Balance Type: | na
Period Type: | instant

X
- Definition Number Of Board Of Directors, Combined Company + References No definition available. + Details
Name: | lenz_NumberOfBoardOfDirectorsCombinedCompany
Namespace Prefix: | lenz_
Data Type: | xbrli:integerItemType
Balance Type: | na
Period Type: | instant

X
- Definition Payables And Accruals Acquired Through Reverse Recapitalization + References No definition available. + Details
Name: | lenz_PayablesAndAccrualsAcquiredThroughReverseRecapitalization
Namespace Prefix: | lenz_
Data Type: | xbrli:monetaryItemType
Balance Type: | credit
Period Type: | duration

X
- Definition Recapitalization Exchange Ratio + References No definition available. + Details
Name: | lenz_RecapitalizationExchangeRatio
Namespace Prefix: | lenz_
Data Type: | xbrli:pureItemType
Balance Type: | na
Period Type: | instant

X
- Definition Reverse Recapitalization, Acceleration Of Stock Awards Expense + References No definition available. + Details
Name: | lenz_ReverseRecapitalizationAccelerationOfStockAwardsExpense
Namespace Prefix: | lenz_
Data Type: | xbrli:monetaryItemType
Balance Type: | debit
Period Type: | duration

X
- Definition Reverse Recapitalization + References No definition available. + Details
Name: | lenz_ReverseRecapitalizationLineItems
Namespace Prefix: | lenz_
Data Type: | xbrli:stringItemType
Balance Type: | na
Period Type: | duration

X
- Definition Cash received on stock transaction after deduction of issuance costs. + References No definition available. + Details
Name: | us-gaap_SaleOfStockConsiderationReceivedOnTransaction
Namespace Prefix: | us-gaap_
Data Type: | xbrli:monetaryItemType
Balance Type: | debit
Period Type: | duration

X
- Definition The number of shares issued or sold by the subsidiary or equity method investee per stock transaction. + References No definition available. + Details
Name: | us-gaap_SaleOfStockNumberOfSharesIssuedInTransaction
Namespace Prefix: | us-gaap_
Data Type: | xbrli:sharesItemType
Balance Type: | na
Period Type: | duration

X
- Definition Percentage of subsidiary's or equity investee's stock owned by parent company after stock transaction. + References No definition available. + Details
Name: | us-gaap_SaleOfStockPercentageOfOwnershipAfterTransaction
Namespace Prefix: | us-gaap_
Data Type: | dtr-types:percentItemType
Balance Type: | na
Period Type: | duration

X
- Definition Number of new stock issued during the period. + References Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef -Name Accounting Standards Codification -Section 50 -Paragraph 2 -SubTopic 10 -Topic 505 -Publisher FASB -URI https://asc.fasb.org/1943274/2147481112/505-10-50-2 Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef -Topic 210 -SubTopic 10 -Name Accounting Standards Codification -Section S99 -Paragraph 1 -Subparagraph (SX 210.5-02(28)) -Publisher FASB -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1 Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef -Topic 210 -SubTopic 10 -Name Accounting Standards Codification -Section S99 -Paragraph 1 -Subparagraph (SX 210.5-02(29)) -Publisher FASB -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1 Reference 4: http://www.xbrl.org/2003/role/disclosureRef -Topic 946 -SubTopic 505 -Name Accounting Standards Codification -Section 50 -Paragraph 2 -Subparagraph (a) -Publisher FASB -URI https://asc.fasb.org/1943274/2147478448/946-505-50-2 Reference 5: http://www.xbrl.org/2003/role/disclosureRef -Topic 946 -SubTopic 220 -Name Accounting Standards Codification -Section S99 -Paragraph 3 -Subparagraph (SX 210.6-09(4)(b)) -Publisher FASB -URI https://asc.fasb.org/1943274/2147479134/946-220-S99-3 Reference 6: http://www.xbrl.org/2003/role/disclosureRef -Topic 946 -SubTopic 10 -Name Accounting Standards Codification -Section S99 -Paragraph 3 -Subparagraph (SX 210.6-03(i)(1)) -Publisher FASB -URI https://asc.fasb.org/1943274/2147479886/946-10-S99-3 Reference 7: http://fasb.org/us-gaap/role/ref/legacyRef -Topic 505 -SubTopic 10 -Name Accounting Standards Codification -Section S99 -Paragraph 1 -Subparagraph (SX 210.3-04) -Publisher FASB -URI https://asc.fasb.org/1943274/2147480008/505-10-S99-1 + Details
Name: | us-gaap_StockIssuedDuringPeriodSharesNewIssues
Namespace Prefix: | us-gaap_
Data Type: | xbrli:sharesItemType
Balance Type: | na
Period Type: | duration

X
- Details
Name: | dei_LegalEntityAxis=lenz_GraphiteBioInc.StockholdersMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | dei_LegalEntityAxis=lenz_PIPEInvestorsMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |